Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

iPLEDGE Vexes Dermatologists Treating Transgender Patients

Publish date:: December 16, 2019

Key clinical point: Registering transgender patients in the iPLEDGE birth isotretinoin registry creates confusion for dermatologists.

Major finding: Half of physicians surveyed said that they encountered difficulties prescribing isotretinoin to transgender patients; 12% have prescribed alternatives to isotretinoin as a result.

Study details: An 18-point survey emailed to 385 academic dermatologists, of which a third responded.

Disclosures: Dr. Ensslin and colleagues reported conflicts of interest related to their research. The study was supported by the National Center for Research Resources and the National Center for Advancing Translational Sciences of the National Institutes of Health.

Citation:

Ensslin C et al. J Am Acad Dermatol. 2019;81(6):1426-9.

This Week's Must Reads

Annual WCC visits significantly limit asthma worsening,

Does daily inhaler monitoring improve asthma outcomes in children?,

More severe AD correlates with worse sleep health and attention problems in children,

COVID-19–induced drop in first measles vaccinations sparks resurgence concerns,

Shortcomings identified in study of acne videos on TikTok,

Must Reads in Dermatology

More severe AD correlates with worse sleep health and attention problems in children,

Shortcomings identified in study of acne videos on TikTok,

No lab monitoring needed in adolescents on dupilumab,

New lupus classification criteria perform well in children, young adults,

COVID-19 outcomes no worse in patients on TNF inhibitors or methotrexate,